1.

Notifying Member: EUROPEAN UNION

If applicable, name of local government involved (Articles 3.2 and 7.2):

2.

Agency responsible:

European Commission

EU-TBT Enquiry Point,

Fax: +(32) 2 299 80 43,

E-mail: grow-eu-tbt@ec.europa.eu

Website: https://technical-barriers-trade.ec.europa.eu/en/home

3.

Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], 3.2 [ ], 7.2 [ ], Other:

4.

Products covered (HS codes or national tariff lines. ICS numbers may be provided in addition, where applicable): Biocidal products

5.

Details of notified document(s) (title, number of pages and languages, means of access): Draft Commission Implementing Decision not renewing the approval of etofenprox for use in biocidal products of product-types 8 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (4 page(s), in English)

Link to notified document(s) and/or contact details for agency or authority which can provide copies upon request:

https://members.wto.org/crnattachments/2025/TBT/EEC/25_06195_00_e.pdf

European Commission

EU-TBT Enquiry Point

Fax: + (32) 2 299 80 43

E-mail: grow-eu-tbt@ec.europa.eu

The text is available on the Website: https://technical-barriers-trade.ec.europa.eu/en/home

6.

Description of content: This draft Commission Implementing Decision does not renew the approval of etofenprox for use in biocidal products of product-types 8 and 18.

On 27 July 2018, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of etofenprox for use in biocidal products of product-type 8.

On 25 October 2023, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of etofenprox for use in biocidal products of product-type 18.

On 12 June 2025, the applicant informed the Commission that it withdrew their applications for the renewal of approval of etofenprox for both product-types of 8 and 18. The draft Decision will therefore propose to not renew the approval of etofenprox for product-types 8 and 18.

In order to allow sufficient time for economic operators to adapt, treated articles treated with or incorporating etofenprox for use in biocidal products of product-types 8 and 18 may be placed on the market for a period of 180 days after the entry into force of this Decision.

7.

Objective and rationale, including the nature of urgent problems where applicable: Protection of human health or safety; Protection of the environment; Harmonization

8.

Relevant documents:

-Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1.). Available in all EU languages.

EUR-Lex - 32012R0528 - EN - EUR-Lex (europa.eu)

9.

Proposed date of adoption: January 2026

Proposed date of entry into force: 20 days from publication in the Official Journal of the EU

10.

Provision of comments

Final date for comments: 18 November 2025

[X] 60 days from notification

Contact details of agency or authority designated to handle comments regarding the notification:

European Commission,

EU-TBT Enquiry Point,

Fax: + (32) 2 299 80 43,

E-mail: grow-eu-tbt@ec.europa.eu